Evidence map›Paper›PMID 33055209›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

Functional interplay among thiol-based redox signaling, metabolism, and ferroptosis unveiled by a genetic variant of

Julia I-Ju Leu, Maureen E Murphy, Donna L George

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Fueling Death: The Metabolic Control of Ferroptosis.Advances in experimental medicine and biology · 2026
    Review
  3. Article
  4. Article
  5. The cell biology of ferroptosis.Nature reviews. Molecular cell biology · 2024
    Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. The African-centric P47S Variant ofCancer research communications · 2023
    Article
  12. Review
  13. Common activities and predictive gene signature identified for genetic hypomorphs ofProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  14. Bioinorganic Modulators of Ferroptosis: A Review of Recent Findings.International journal of molecular sciences · 2023
    Review
  15. Article
  16. Article
  17. Article
  18. Targeting ErbB3 and Cellular NADPH/NADPACS chemical biology · 2022
    Article
  19. Review
  20. Ferroptosis regulation by the NGLY1/NFE2L1 pathway.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Julia I-Ju LeuDepartment of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.
Maureen E MurphyProgram in Molecular and Cellular Oncogenesis, The Wistar Institute, Philadelphia, PA 19104 mmurphy@wistar.org georged@pennmedicine.upenn.edu.ORCID 0000-0001-7644-7296
Donna L GeorgeDepartment of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104; mmurphy@wistar.org georged@pennmedicine.upenn.edu.
University of Pennsylvania · USThe Wistar Institute · US

Funding

Tumor Microenvironment and MetastasisP30CA010815 · NCI · WISTAR INSTITUTE · PI Luis J Montaner · 1985 to 2026
$75.9M
Targeting the MAP and PI3 Kinase Pathways in MelanomaP01CA114046 · NCI · WISTAR INSTITUTE · PI MURPHY, MAUREEN E. · 2008 to 2023
$37.1M
TRANSGENIC AND CHIMERIC MOUSE COREP30DK050306 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI REBECCA G WELLS · 1997 to 2026
$32.5M
Transformed Esophageal Epithelial Cells and the Tumor MicroenvironmentP01CA098101 · NCI · UNIVERSITY OF PENNSYLVANIA · PI RUSTGI, ANIL K · 2003 to 2023
$31.7M
ZINC FINGER PROTEINS IN EARLY KIDNEY DEVELOPMENTP01DK049210 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI KAESTNER, KLAUS H · 1995 to 2016
$26.9M
Functional Analysis of p53 Polymorphic Variants - Diversity SupplementR01CA102184 · NCI · WISTAR INSTITUTE · PI Maureen E. Murphy · 2005 to 2026
$7.4M
The ARF Tumor SuppressorR01CA139319 · NCI · WISTAR INSTITUTE · PI MURPHY, MAUREEN E. · 2010 to 2019
$3.9M
NCI NIH HHS P01 CA098101NCI NIH HHS P01 CA114046NCI NIH HHS P30 CA010815NCI NIH HHS R01 CA102184NCI NIH HHS R01 CA139319NIDDK NIH HHS P01 DK049210NIDDK NIH HHS P30 DK050306
6 · The paper itself

Abstract

The p53 tumor suppressor protein is a transcription factor and master stress response mediator, and it is subject to reduction-oxidation (redox)-dependent regulation. The P47S variant of

Indexed as

FerroptosisGenes, p53Oxidation-ReductionActivating Transcription Factor 4AnimalsCell LineCoenzyme AGlutathioneGlycolysisHomeostasisHumansMaleMiceProtein Processing, Post-TranslationalSulfhydryl CompoundsActivating Transcription Factor 4Coenzyme AGlutathioneSulfhydryl CompoundsATF4coenzyme Acysteine modificationsferroptosisp53

Identifiers

PMID33055209
PMCPMC7604449
OpenAlexW3092668098

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.